Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LIPG | Q9Y5X9 | 10/20 | 0.43 |
| ▸ | LPL | P06858 | 9/20 | 0.43 |
| ▸ | HIF1A | Q16665 | 2/20 | 0.39 |
| ▸ | F11 | P03951 | 2/20 | 0.38 |
| ▸ | GABRA1 | P14867 | 1/20 | 0.38 |
| ▸ | GABRB2 | P47870 | 1/20 | 0.38 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.36 |
| ▸ | F2 | P00734 | 1/20 | 0.36 |
| ▸ | PRSS1 | P07477 | 1/20 | 0.36 |
| ▸ | PRSS2 | P07478 | 1/20 | 0.36 |
| ▸ | PRSS3 | P35030 | 1/20 | 0.36 |
| ▸ | ROCK1 | Q13464 | 1/20 | 0.36 |
| ▸ | CA1 | P00915 | 2/20 | 0.36 |
| ▸ | CA2 | P00918 | 2/20 | 0.36 |
| ▸ | CA9 | Q16790 | 2/20 | 0.36 |
| ▸ | CA12 | O43570 | 1/20 | 0.36 |
| ▸ | CA3 | P07451 | 1/20 | 0.36 |
| ▸ | CA4 | P22748 | 1/20 | 0.36 |
| ▸ | CA6 | P23280 | 1/20 | 0.36 |
| ▸ | CA5A | P35218 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21791108 | 0.86 | LIPG (0.53) | LIPGLPLHIF1AF11FFAR1 | |
| SCHEMBL21682668 | 0.81 | HIF1A (0.50) | LIPGLPLHIF1AF11ROCK1 | |
| SCHEMBL21341781 | 0.78 | LIPG (0.51) | LIPGLPLHIF1AF11ROCK1 | |
| SCHEMBL21236362 | 0.76 | LIPG (0.50) | LIPGLPLHIF1AF11ROCK1 | |
| SCHEMBL16011263 | 0.76 | ROCK1 (0.44) | LIPGLPLHIF1AF11FFAR1 | |
| SCHEMBL16866325 | 0.75 | LIPG (0.49) | LIPGLPLHIF1AF11F2 | |
| SCHEMBL23770467 | 0.75 | LIPG (0.47) | LIPGLPLHIF1AF11ROCK1 | |
| SCHEMBL22407974 | 0.75 | ROCK1 (0.43) | LIPGLPLHIF1AF11FFAR1 | |
| SCHEMBL22408147 | 0.75 | LIPG (0.36) | LIPGLPLHIF1AF11FFAR1 | |
| SCHEMBL517499 | 0.75 | LPL (0.52) | LIPGLPLF11FFAR1CA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7122694-B2 | Hydroboronation process | BORON MOLECULAR PTY LIMITED (AU) | 2006-10-17 | — | — | US | disclosed |
| US-20040133028-A1 | Hydroboronation process | COMMONWEALTH SCIENTIFIC | 2004-07-08 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040133028-A1 | Hydroboronation process | ALKBH3, HPD, HVCN1 | LIPG 4522/4885LPL 4659/4885HIF1A 1375/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.